Table 1.
Overall (n = 34,169) n (%) | R-MS (n = 30,083) n (%) | PPMS (n = 4086) n (%) | |
---|---|---|---|
Vital status as of 2016/01/01 | |||
Deceased | 1849 (5.4%) | 1311 (4.4%) | 538 (13.2%) |
Lost to follow-up | 2350 (6.9%) | 2054 (6.8%) | 296 (7‧2%) |
Alive | 29,970 (87.7%) | 26,718 (88.8%) | 3252 (79.6%) |
Sex | |||
Men | 9848 (28.8%) | 8057 (26.8%) | 1791 (43.8%) |
Women | 24,321 (71.2%) | 22,026 (73.2%) | 2295 (56.2%) |
EDI | |||
Median [percentiles 2.5; 97.5] | −0.6 [−5.6; 11.9] | −0.6 [−5.6; 11.8] | −0.6 [−5.5; 12.6] |
Age at MS onset | |||
Median [quartiles 1–3] | 31.7 [24.9–40.0] | 30.4 [24.3–38.1] | 43.2 [35.0–50.3] |
Year of onset of symptoms | |||
[1960–1970] | 655 (1.9%) | 602 (2.0%) | 53 (1.3%) |
[1970–1980] | 2114 (6.2%) | 1926 (6.4%) | 188 (4.6%) |
[1980–1990] | 5025 (14.7%) | 4449 (14.8%) | 576 (14.1%) |
[1990–2000] | 9917 (29.0%) | 8628 (28.7%) | 1289 (31.6%) |
[2000–2010] | 12,155 (35.6%) | 10,545 (35.1%) | 1610 (39.4%) |
[2010–2015] | 4303 (12.6%) | 3933 (13.1%) | 370 (9.1%) |
Follow-up (years) | |||
Median [quartiles 1–3] | 15.7 [9.1–23.7] | 15.8 [9.0–24.0] | 15.2 [9.6–22.0] |